221 related articles for article (PubMed ID: 33946738)
1. Hepatic Wnt1 Inducible Signaling Pathway Protein 1 (WISP-1/CCN4) Associates with Markers of Liver Fibrosis in Severe Obesity.
Pivovarova-Ramich O; Loske J; Hornemann S; Markova M; Seebeck N; Rosenthal A; Klauschen F; Castro JP; Buschow R; Grune T; Lange V; Rudovich N; Ouwens DM
Cells; 2021 Apr; 10(5):. PubMed ID: 33946738
[TBL] [Abstract][Full Text] [Related]
2. Wnt-induced secreted protein 1/CCN4 in liver fibrosis both in vitro and in vivo.
Jian YC; Wang JJ; Dong S; Hu JW; Hu LJ; Yang GM; Zheng YX; Xiong WJ
Clin Lab; 2014; 60(1):29-35. PubMed ID: 24600972
[TBL] [Abstract][Full Text] [Related]
3. WISP1 is a novel adipokine linked to inflammation in obesity.
Murahovschi V; Pivovarova O; Ilkavets I; Dmitrieva RM; Döcke S; Keyhani-Nejad F; Gögebakan Ö; Osterhoff M; Kemper M; Hornemann S; Markova M; Klöting N; Stockmann M; Weickert MO; Lamounier-Zepter V; Neuhaus P; Konradi A; Dooley S; von Loeffelholz C; Blüher M; Pfeiffer AF; Rudovich N
Diabetes; 2015 Mar; 64(3):856-66. PubMed ID: 25281430
[TBL] [Abstract][Full Text] [Related]
4. WNT1-inducible-signaling pathway protein 1 regulates the development of kidney fibrosis through the TGF-β1 pathway.
Wang B; Ding X; Ding C; Tesch G; Zheng J; Tian P; Ricardo S; Shen HH; Xue W
FASEB J; 2020 Nov; 34(11):14507-14520. PubMed ID: 32896021
[TBL] [Abstract][Full Text] [Related]
5. WISP1 aggravates cell metastatic potential by abrogating TGF-
Song D; Wang L; Su K; Wu H; Li J
Exp Biol Med (Maywood); 2021 Jun; 246(11):1244-1252. PubMed ID: 33593111
[TBL] [Abstract][Full Text] [Related]
6. CCN4/WISP-1 positively regulates chondrogenesis by controlling TGF-β3 function.
Yoshioka Y; Ono M; Maeda A; Kilts TM; Hara ES; Khattab H; Ueda J; Aoyama E; Oohashi T; Takigawa M; Young MF; Kuboki T
Bone; 2016 Feb; 83():162-170. PubMed ID: 26555637
[TBL] [Abstract][Full Text] [Related]
7. Assessment of circulating Wnt1 inducible signalling pathway protein 1 (WISP-1)/CCN4 as a novel biomarker of obesity.
Tacke C; Aleksandrova K; Rehfeldt M; Murahovschi V; Markova M; Kemper M; Hornemann S; Kaiser U; Honig C; Gerbracht C; Kabisch S; Hörbelt T; Ouwens DM; Weickert MO; Boeing H; Pfeiffer AFH; Pivovarova O; Rudovich N
J Cell Commun Signal; 2018 Sep; 12(3):539-548. PubMed ID: 29129025
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor binding protein related protein 1 knockdown attenuates hepatic fibrosis via the regulation of MMPs/TIMPs in mice.
Ren JJ; Huang TJ; Zhang QQ; Zhang HY; Guo XH; Fan HQ; Li RK; Liu LX
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):38-47. PubMed ID: 30243878
[TBL] [Abstract][Full Text] [Related]
9. CCN4/WISP1 controls cutaneous wound healing by modulating proliferation, migration and ECM expression in dermal fibroblasts via α5β1 and TNFα.
Ono M; Masaki A; Maeda A; Kilts TM; Hara ES; Komori T; Pham H; Kuboki T; Young MF
Matrix Biol; 2018 Aug; 68-69():533-546. PubMed ID: 29330021
[TBL] [Abstract][Full Text] [Related]
10. WNT1-inducible signaling protein-1 mediates TGF-β1-induced renal fibrosis in tubular epithelial cells and unilateral ureteral obstruction mouse models via autophagy.
Yang X; Wang H; Tu Y; Li Y; Zou Y; Li G; Wang L; Zhong X
J Cell Physiol; 2020 Mar; 235(3):2009-2022. PubMed ID: 31512238
[TBL] [Abstract][Full Text] [Related]
11. Wnt2 and WISP-1/CCN4 Induce Intimal Thickening via Promotion of Smooth Muscle Cell Migration.
Williams H; Mill CA; Monk BA; Hulin-Curtis S; Johnson JL; George SJ
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1417-24. PubMed ID: 27199447
[TBL] [Abstract][Full Text] [Related]
12. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.
Deng W; Fernandez A; McLaughlin SL; Klinke DJ
J Biol Chem; 2019 Apr; 294(14):5261-5280. PubMed ID: 30723155
[TBL] [Abstract][Full Text] [Related]
13. CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer.
Gurbuz I; Chiquet-Ehrismann R
Int J Biochem Cell Biol; 2015 May; 62():142-6. PubMed ID: 25794425
[TBL] [Abstract][Full Text] [Related]
14. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
[TBL] [Abstract][Full Text] [Related]
15. WISP1/CCN4 inhibits adipocyte differentiation through repression of PPARγ activity.
Ferrand N; Béreziat V; Moldes M; Zaoui M; Larsen AK; Sabbah M
Sci Rep; 2017 May; 7(1):1749. PubMed ID: 28496206
[TBL] [Abstract][Full Text] [Related]
16. Prospects and Perspectives for WISP1 (CCN4) in Diabetes Mellitus.
Maiese K
Curr Neurovasc Res; 2020; 17(3):327-331. PubMed ID: 32216738
[TBL] [Abstract][Full Text] [Related]
17. Optimal CCN4 Immunofluorescence for Tissue Microarray.
Gaudreau PO; Cousineau I; Stagg J
Methods Mol Biol; 2023; 2582():13-21. PubMed ID: 36370340
[TBL] [Abstract][Full Text] [Related]
18. Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis.
Kim J; Kang W; Kang SH; Park SH; Kim JY; Yang S; Ha SY; Paik YH
Sci Rep; 2020 Dec; 10(1):21018. PubMed ID: 33273492
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.
Osawa Y; Hoshi M; Yasuda I; Saibara T; Moriwaki H; Kozawa O
PLoS One; 2013; 8(6):e65251. PubMed ID: 23755201
[TBL] [Abstract][Full Text] [Related]
20. Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-β/Smad signaling pathways.
Li XM; Peng JH; Sun ZL; Tian HJ; Duan XH; Liu L; Ma X; Feng Q; Liu P; Hu YY
Acta Pharmacol Sin; 2016 Jun; 37(6):783-93. PubMed ID: 27133300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
